Digital Health in 2026: what we're seeing from the marketing side
This is a running perspective that we update as the market moves. It is a marketing view, not a policy analysis, and it deliberately avoids predictions we cannot support.
Policy momentum is real, and it raises the floor
With the 10 Year Health Plan placing digital transformation at the centre of NHS reform, and the Life Sciences Sector Plan reinforcing it, the sector has genuine tailwinds. The consequence for individual suppliers is more competition for attention, not less.
AI categories are converging on identical language
Across ambient documentation, triage, diagnostics support and operational AI, supplier messaging is becoming interchangeable. Companies that describe their specific function precisely are increasingly the exception, and benefit from it.
Claims are being read more carefully
As formal attention to AI in healthcare increases, buyers are more alert to language that outruns evidence. Careful, dated, specific communication is now a commercial advantage rather than a constraint.
The product-to-market gap is the recurring theme
The single most common situation we encounter is a strong, well-evidenced product attached to a brand, website and content presence built two or three years earlier for a different stage of the business. Product development has moved. Market presence has not.
Founder visibility is doing more work
In a market where buyers research quietly and at length before contact, what the people behind a company say publicly is increasingly part of the evaluation.
This article refers to a position current at the date above and is reviewed when the underlying guidance or policy changes. Clarity Media Co. comments on the marketing and commercial implications of developments in Digital Health and HealthTech. We do not provide clinical, regulatory, DTAC or legal advice.